Difference between revisions of "Chuang Lab"
| Line 20: | Line 20: | ||
|direction=right | |direction=right | ||
|title = News | |title = News | ||
| − | |section = [http://chuanglab.org/News | + | |section = [http://chuanglab.org/News PDXNet U24 grant] |
|image=jeff-chuang-9922mirrored.jpg | |image=jeff-chuang-9922mirrored.jpg | ||
|width=45% | |width=45% | ||
| − | |quote= | + | |quote= The lab has been awarded a National Cancer Institute grant to continue our coordination of data sharing and analysis to general cancer clinical trials for the PDXNet. We are working with institutes including MD Anderson, Dana Farber, Huntsman Cancer Institute, Baylor College of Medicine, the Wistar Institute, Washington University, UC Davis, and Virginia Commonwealth University. For this project we will be analyzing hundreds of new and existing PDX samples toward the goal of developing a clinical trial based on patient-derived xenografts.}} |
</div> | </div> | ||
</div> | </div> | ||
Revision as of 10:50, 12 April 2024
Our lab uses computational and mathematical approaches to investigate the mechanisms that govern cancer cells and their spatial interactions. The lab specializes in problems in cancer image analysis, genomics, and evolution.
The lab uses computational and mathematical approaches to understand cancer cells nd their spatial interactions. We develop and apply techniques from a variety of disciplines, including deep neural networks, genomic and evolutionary analysis, and biophysical modeling. We are currently focused in: 1) Multiplex and histopathological cancer image analysis using deep learning, and 2) Cancer evolution in response to therapy.
PDXNet U24 grant
The lab has been awarded a National Cancer Institute grant to continue our coordination of data sharing and analysis to general cancer clinical trials for the PDXNet. We are working with institutes including MD Anderson, Dana Farber, Huntsman Cancer Institute, Baylor College of Medicine, the Wistar Institute, Washington University, UC Davis, and Virginia Commonwealth University. For this project we will be analyzing hundreds of new and existing PDX samples toward the goal of developing a clinical trial based on patient-derived xenografts.
